OSTXNYSEPharmaceutical PreparationsFiscal year ends December 31
OS Therapies Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.27−0.05 (-3.79%)
Close on Oct 19, 2026
- Market cap
- $55.76M
- P/E (TTM)
- –
- Dividend yield
- –
OS Therapies statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | OS Therapies | Industry median |
|---|---|---|
| Market Cap | $58.58M | $166.30M |
| Enterprise Value | $58.37M | $88.19M |
Income (trailing twelve months)
| Measure | OS Therapies | Industry median |
|---|---|---|
| Operating Income | -$37.61M | -$21.40M |
| Net Income | -$39.37M | -$22.46M |
| EBITDA | -$37.11M | -$16.91M |
| EPS (Diluted) | -$1.07 | -$0.83 |
Returns
| Measure | OS Therapies | Industry median |
|---|---|---|
| Return on Assets (ROA) | -389.6% | -40.9% |
Balance sheet
| Measure | OS Therapies | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $205.04K | $61.43M |
| Net Cash (Debt) | $205.04K | $15.35M |
| Net Cash Per Share | $0.00 | $0.66 |
| Equity (Book Value) | -$11.91M | $49.09M |
| Book Value Per Share | -$0.26 | $1.37 |
| Tangible Book Value | -$18.17M | $23.52M |
| Working Capital | -$17.00M | $76.81M |
Financial position
| Measure | OS Therapies | Industry median |
|---|---|---|
| Current Ratio | 0.18 | 3.34 |
| Quick Ratio | 0.01 | 2.44 |
Cash flow (trailing twelve months)
| Measure | OS Therapies | Industry median |
|---|---|---|
| Operating Cash Flow | -$18.53M | -$12.35M |
Efficiency
| Measure | OS Therapies | Industry median |
|---|---|---|
| Profits Per Employee | -$39.37K | -$703.34K |
| Employee Count | 1,000 | 74 |
Dividends and yields
| Measure | OS Therapies | Industry median |
|---|---|---|
| Earnings Yield | -67.2% | -23.3% |
Shares
| Measure | OS Therapies | Industry median |
|---|---|---|
| Shares Outstanding | 46,125,800 | 58,127,000 |
| Shares Change (YoY) | 77.8% | 10.9% |
| Shares Change (QoQ) | 15.3% | 0.54% |
| Float | 40,184,900 | 49,136,700 |
| Shares Held by Insiders | 12.9% | 11.6% |
| Shares Held by Institutions | 6.28% | 59.4% |
Scores
| Measure | OS Therapies | Industry median |
|---|---|---|
| Altman Z-Score | -25.10 | -0.22 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from OS Therapies's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.